CTKB CapEx to Revenue

Cytek Biosciences Inc · CapEx to Revenue

CTKB logo

CTKB CapEx to Revenue

Current (TTM)2.92%
CTKB CapEx/Revenue (1.68% → 2.92%)
High-resolution chart · PNG

CTKB capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytek Biosciences Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
2.0269%
1.7585%
2.5008%
6.0158%
3.4107%
1.6663%
1.681%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.